Also, although BARD1 was included in the most recent version of “The National Comprehensive Cancer Network (NCCN) Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian” as a gene that may be linked with increased breast cancer risk, still due to insufficient evidence, no management recommendations for women with a pathogenic BARD1 variant was provided at this time. The gene discussed is BARD1; the disease is breast cancer.